Protalix BioTherapeutics
PLX
#8687
Rank
NZ$0.30 B
Marketcap
NZ$3.72
Share price
1.42%
Change (1 day)
-17.63%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$12.95 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.84 Million. In 2024 the company made an earning of NZ$9.07 Million a decrease over its 2023 earnings that were of NZ$20.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$12.95 M42.75%
2024 NZ$9.07 M-55.62%
2023 NZ$20.45 M-199.05%
2022 -NZ$20.65 Million-40.38%
2021 -NZ$34.64 Million-732.31%
2020 NZ$5.47 M-130.53%
2019 -NZ$17.94 Million189.85%
2018 -NZ$6.19 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.21 Million-32.37%
2015 -NZ$47.63 Million10.11%
2014 -NZ$43.26 Million-7.59%
2013 -NZ$46.81 Million
2011 -NZ$54.2 Million-19.39%
2010 -NZ$67.24 Million20.87%
2009 -NZ$55.63 Million32.26%
2008 -NZ$42.06 Million-5.46%
2007 -NZ$44.49 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.68 Million1.03%
2000 -NZ$0.67 Million-53.22%
1999 -NZ$1.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.73 B 136,540.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.10 B 8,433.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.74 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel